Victor Urrea Gales

12PUBLICATIONS
46CO-AUTHORS
Technology, crime and surveillanceInnate immunityAgricultural molecular engineering of nucleic acids and proteinsGene and molecular therapyAnimal protection (incl. pests and pathogens)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 22, 2025
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.

Lucia Bailón, Yovaninna Alarcón-Soto, Angel Rivero

|Oct 26, 2024
Immunoaging at Early Ages Could Drive a Higher Comorbidity Burden in People with HIV on Antiretroviral Therapy Compared with the Uninfected Population.

Cora Loste, Macedonia Trigueros, Francisco Muñoz-López

|Jun 27, 2024
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein.

Raquel Ortiz, Ana Barajas, Anna Pons-Grífols

|Mar 22, 2024
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.

Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo

|Feb 27, 2024
Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models.

Carla Usai, Erola Ainsua-Enrich, Victor Urrea Gales

|Feb 05, 2024
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.

Leire de Campos-Mata, Benjamin Trinité, Andrea Modrego

Pageof 2